NewGenIvf Group Limited (NIVF) Earnings History
Annual and quarterly earnings data from 2021 to 2024
Loading earnings history...
NIVF EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NIVF Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 33.6% | -21.4% | -9.7% |
| 2023 | 32.7% | 0.8% | 2.5% |
| 2022 | 25.9% | -8.5% | 7.7% |
| 2021 | 24.9% | 4.8% | -0.0% |
Download Data
Export NIVF earnings history in CSV or JSON format
Free sign-in required to download data
NewGenIvf Group Limited (NIVF) Earnings Overview
As of May 8, 2026, NewGenIvf Group Limited (NIVF) reported trailing twelve-month net income of -$461,617, reflecting -279.4% year-over-year growth. The company earned $-0.81 per diluted share over the past four quarters, with a net profit margin of -9.7%.
Looking at the long-term picture, NIVF's historical earnings data spans multiple years. The company achieved its highest annual net income of $458,667 in fiscal 2022.
NewGenIvf Group Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NTRA (-$208M net income, -9.0% margin), PGNY ($68M net income, 4.5% margin), TMHC ($672M net income, 9.6% margin), NIVF has room to improve margins relative to the peer group. Compare NIVF vs NTRA →
NIVF Earnings vs Peers
Earnings metrics vs comparable public companies
NIVF Historical Earnings Data (2021–2024)
4 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $-525,000 | -503.2% | -$1M | $-23.05 | -9.7% | -21.4% |
| 2023 | $130,193 | -71.6% | $42,242 | $12.85 | 2.5% | 0.8% |
| 2022 | $458,667 | +86153.8% | $-504,907 | $64.60 | 7.7% | -8.5% |
| 2021 | $-533 | - | $198,758 | $-0.01 | -0.0% | 4.8% |
See NIVF's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NIVF Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NIVF vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNIVF — Frequently Asked Questions
Quick answers to the most common questions about buying NIVF stock.
Is NIVF growing earnings?
NIVF EPS fell to $-0.81, with earnings declining -279.4%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-461617.00.
What are NIVF's profit margins?
NewGenIvf Group Limited net margin is -9.7%, with operating margin at -21.4%. Below-average margins reflect competitive or cost pressures.
How consistent are NIVF's earnings?
NIVF earnings data spans 2021-2024. The declining earnings trend is -279.4% YoY. Historical data enables comparison across business cycles.